Intraocular Lens (IOLs) Market by Overview, Growth Opportunities, Manufacturing Cost Structure Analysis, Regional Outlook
The global intraocular
lens market is expected to grow in the forecast period due to growing
number of vision correction procedures, advances and innovations in intraocular
lens products and cataract procedures and increasing prevalence of cataract. On
the basis of product, the market is expected to be led by monofocal lens as
they have a fixed focus for one distance, are less expensive and are beneficial
for patients with cataract in both eyes.
The IOL
market is segmented on the basis of product, material and end user. PMMA,
silicone and hydrophobic acrylic are the most commonly used materials for
manufacturing lenses, other than these, hydrophilic acrylates and collamer are
also used. The different type of lenses available in the market are monofocal
and premium. Further, different types of premium lenses include accommodating,
toric, phakic, blue light filtering and aspheric lenses.
Download
Report Sample at:
Due to
increasing population it becomes difficult for the ophthalmologists to conduct
cataract or any other eye related surgeries. According to the American
Geriatrics Society (AGS), around 20% of Americans are expected to be more than
65 years of age by 2030, and 21% of those over 60 years of age are likely to
undergo a surgical procedure.
Untapped
emerging market and advancements in phacoemulsification and intraocular lens
technology have ushered in a new era of cataract surgery in the market. In
November 2017, the United States Food and Drug Administration (USFDA) approved
an IOL system namely, RxSight Inc. Light Adjustable Lens and Light Delivery
Device. This lens is applicable for the patients with pre-existing astigmatism
of ≥0.75 diopters undergoing, cataract surgery and offers adjustment
post-operatively to improve uncorrected visual acuity.
Some of the
key players operating in the IOL industry include Johnson & Johnson, Carl
Zeiss Meditec AG, Valeant Pharmaceuticals International, Inc., Novartis AG,
Oculentis GmbH, Eyekon Medical, Inc., STAAR Surgical Company, and HumanOptics
AG.
Comments
Post a Comment